Navigation Links
Assessing dangerous climate change and call for climate change response papers
Date:12/3/2013

examining the potential for drawing down atmospheric CO2 via reforestation and increase of soil carbon, Hansen et al review fossil fuel emission reduction scenarios, concluding that an appropriate target is to keep global temperature within or close to the temperature range in the Holocene, the interglacial period in which civilization developed.

Following on from the PLOS Collection "Ecological Impacts of Climate Change" the publication of this paper is accompanied by a call for papers for responses to climate change.

"Our hope is to generate a wide range of submissions on climate research and in particular papers that address solutions to the challenges posed by a changing climate, such as alternative energy development, environmental preservation, the problems of acidification, adaptation strategies and restoration of failing ecosystems. As a multidisciplinary and open access journal, PLOS ONE is well equipped to handle the variety of submissions we hope to receive and make that research freely available to the world for application and further development" says Damian Pattinson, Editorial Director of PLOS ONE.

Papers submitted to the call that successfully undergo peer review will be published in PLOS ONE. A PLOS Collection, "Responding to Climate Change," will be launched in early 2014 to highlight the research.


'/>"/>

Contact: Jennifer Horsley
collections@plos.org
44-122-344-2836
Public Library of Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. Climate change, people and ecosystems:Assessing strategies for adaptation
2. Assessing noise impact of offshore wind farm construction may help protect marine mammals
3. Public lecture at UC Riverside to discuss challenges in assessing human impact on ecosystems
4. Assessing a new technique for ensuring fresh produce remains Salmonella-free
5. Model of dangerous bee disease in Jersey provides tool in fight against honeybee infections
6. Smoking + asthma + pregnant = a dangerous combination
7. MRI measure of blood flow over atherosclerotic plaque may detect dangerous plaque
8. Study: Widespread test-and-treat HIV policies could increase dangerous drug resistance
9. Social bees mark dangerous flowers with chemical signals
10. Shedding new light on one of diabetes most dangerous complications
11. The raccoon spreads dangerous diseases as it invades Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
(Date:3/24/2015)... WASHINGTON , March 24, 2015   NexID ... applications with critical security-authentication needs, today announced the beginning ... fake-finger-detection (FFD) solution. The company, based in ... announcement at the three-day Connect:ID Expo, which began here ... NexID said version 2.0 of its SDK boosts ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... award in the "commercial" category of Illumina,s Data Excellence ... of. iDEA is Illumina,s program designed to challenge the ... data analysis techniques. "The iDEA challenge really sparked ... about it. Genomatix is a scientific company at heart, ...
... Today someone in a remote village in India is ... on a loved one having a potential heart attack and ... Mobile technology is already bringing health care to places ... still room for error that can lead to misdiagnosis. ...
... University] All the excitement about nanotechnology comes down ... billionths of a meter take on unusual properties. Technologists ... but new research by an interdisciplinary team of scientists ... a cellular pathway that contributes to cancer in human ...
Cached Biology News:UT researchers develop algorithm to improve remote electrocardiography 2Nickel nanoparticles may contribute to lung cancer 2
(Date:5/5/2015)... 2015   Tocagen Inc. , a clinical-stage ... Parkinson , M.D., a venture partner at New ... board of directors of Tocagen. Dr. Parkinson has ... clinical development, including leading clinical activities at Amgen ... the cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and ...
(Date:5/5/2015)... 5, 2015  Indianapolis-based medical device manufacturer NICO ... line of products including the BrainPath® and Myriad™ ... deep-seated brain abnormalities and then removing affected tissue. ... more than 50 institutions throughout the ... been included in 12 abstracts, three peer-reviewed publications, ...
(Date:5/4/2015)... 4, 2015 Many of us take ... certain infants with rare, inherited mutations of certain ... of their impaired immune responses. Now, ... an important role for calcium signaling in immune ... the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)... 2015   St. Jude Children,s Research Hospital ... tool for finding genetic alterations that play an ... to identify with whole-genome sequencing. The findings appear ... . The tool is an algorithm ... Regression Tree in Next Generation Sequencing. ...
Breaking Biology Technology:Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4
... Will Increase Productivity to Meet Growing Global Demand , ... Jakarta, Indonesia ... Center for Rice Research (ICRR) today announced an agreement that grants ... rice hybrids in Asia. , , , , ,Rice is the most ...
... world,s first omega-3 enhanced water is available for ... Zymes Omega Solutions, Inc., an affiliate of Zymes ... the world,s first omega-3 enhanced water, OmegaChill ... water uses Zymes, PTS technology to solubilize and ...
... Helix BioPharma Corp. (TSX, FSE: "HBP") announced that ... Germany to initiate its planned Phase II pharmacokinetic ... low-grade cervical lesions.The clinical study was designed, as ... the absorption and elimination profile of Topical Interferon ...
Cached Biology Technology:DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 2DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 3Zymes Omega Solutions Bottles and Launches the World's First Omega-3 Enhanced Water 2Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions 2Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions 3Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions 4Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions 5
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
This application changes sensitive keywords in an FCS file to remove patient information. It was contributed by Dr. David Miller....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: